Contributor: Gianluca Quaglio

Gianluca QuaglioGianluca Quaglio works in the European Parliament Research Service (EPRS) as policy analyst in health and research policies sectors. He obtained a degree in Medicine from Verona University and a PhD in International Health at the Maastricht University. Before he joined the EPRS, he worked as a clinician and clinical researcher at Verona University Hospital and as scientific project officer in the European Commission, DG Research. He has published over a hundred articles in international peer-review scientific journals.

Coronavirus Covid-19 treatment illustration banner

A scientist’s opinion : Interview with Prof Massimo Galli about covid-19 treatment

Massimo Galli is Professor of Infectious Diseases, Director of the Department of Biomedical and Clinical Sciences Luigi Sacco, University of Milan, and Director of Infectious Diseases III Division, ASST Fatebenefratelli Sacco, Luigi Sacco Hospital, Milan, Italy. He is one of Italy’s leading COVID-19 experts. He has published hundreds of scientific articles in international peer-reviewed journals. ...

Coronavirus Covid-19 treatment illustration banner

Dexamethasone : the first life-saving drug for COVID-19 patients

Clinical trials make it possible to evaluate whether a treatment improves outcomes. Developing a hypothesis, for example if treatment A is better than standard treatment B, clinical trials enable understanding of the role of an intervention in improving patient care. In the current search for a successful treatment against COVID-19, ongoing multiple clinical trials have started to make a difference, such as the Recovery clinical trial on dexamethasone, which has given a definitive verdict on the use of corticosteroids during COVID-19.

Coronavirus Covid-19 treatment illustration banner

A scientist’s opinion : Interview with Prof Martin Landray about covid-19 treatment

Interview with Martin Landray, Professor of Medicine and Epidemiology at the Nuffield Department of Population Health, University of Oxford, Oxford, UK. He is one of the main researchers participating in the Recovery study on dexamethasone. The study was published in the New England Journal of Medicine on 17 July 2020. What are the main conclusions ...

COVID-19 in Africa: what is at stake?

COVID-19 in Africa: what is at stake?

SARS-CoV-2 has arrived in Africa and, progressively, almost all African countries have closed their borders and imposed various levels of "lockdowns" in the hope of limiting the spread of the pandemic, taking measures similar to those taken elsewhere in the world. The pandemic is producing shocking statistics and tragic consequences in developed regions of the ...

The challenges of tackling Covid-19 in Africa

The challenges of tackling Covid-19 in Africa

Interview with Dr John N. Nkengasong, Director of Africa Centres for Disease Control and Prevention about the current situation with the spread of COVID-19 across Africa, about the main risks, challenges and lessons learnt from the HIV/AIDS pandemic and Ebola epidemic.

Covid-19 exclusive interviews : Dr Ilaria Capua

Ilaria Capua: A preparedness plan against unknown viruses is crucial for Europe

Interview on COVID-19 with Ilaria Capua, DVM, PhD, Director of the One Health Center of Excellence for Research and Training, University of Florida, USA. There are tests for COVID-19 which detects the virus, other which detects antibodies. Could you briefly describe the differences of these two tests? The rapid spread of the outbreak required rapid ...

Covid-19 Exclusive interview with Prof. Andrea Crisanti

Prof. Andrea Crisanti: “Active surveillance is crucial in containing the epidemic”

Interview on corona virus and what is the best approach to fight epidemic with Andrea Crisanti, professor of Microbiology and Clinical Microbiology and director of the Department of Molecular Medicine at the University of Padua. From your experience in Italy what should have been the best approach to fight epidemic? I have been repeating since ...